Rightslink® by Copyright Clearance Center

HL-398: Five-Year Overall Survival from the CheckMate 205 Study of Nivolumab for Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL)

Author:

Stephen Ansell,Paul Bröckelmann,Gottfried von Keudell,Hun Ju Lee,Armando Santoro,Pier Luigi Zinzani,Graham Collins,Jonathon Cohen,Jan Paul De Boer,John Kuruvilla,Kerry Savage,Marek Trněný,Mariano Provencio,Ulrich Jaeger,Wolfgang Willenbacher et al.

Publication:

Clinical Lymphoma Myeloma and Leukemia

Publisher:

Elsevier

Date:

September 2021

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Content Excluded

This content has been excluded from the RightsLink's service. Please contact Elsevier directly with your request.